EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Elevated periostin level in serum of adults with osteogenesis imperfecta is associated with disease severity

Alexandre Mercier-Guery iD, Maxime Auroux iD, Evelyne Gineyts iD, Olivier Borel, Pawel Szulc iD, Elisabeth Sornay-Rendu iD, Elisabeth Fontanges iD, Martine Croset iD, Jean-Charles Rousseau iD, Roland Chapurlat iD

The Journal of Clinical Endocrinology & Metabolism · 13.08.2026 · 111 (9) · 2641-2648

DOI: 10.1210/clinem/dgag119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 17.03.2026. Verfasst von Alexandre Mercier-Guery und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hospices Civils de Lyon, Hôpital E.Herriot, Service de Rhumatologie et Pathologie Osseuse, Lyon 69003, France. Hauptthemen laut MEDLINE: Periostin, Osteogenesis Imperfecta, Cell Adhesion Molecules. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: INSERM, 1033 department's own funds, University Hospital of Lyon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In osteogenesis imperfecta (OI), phenotypic variability and the limited predictive value of genotype–phenotype correlations underscore the need for reliable predictive marker of disease severity. Periostin is a matricellular protein involved in bone formation, remodeling, and response to mechanical stress. It interacts with type I collagen and modulates osteoblast activity via Wnt/β-catenin and TGF-β signaling. Given its established role in other bone disorders, we hypothesized that circulating periostin may be a relevant biomarker in OI.

Methods

We performed a matched case–control analysis of serum periostin levels in 61 adult patients with OI and 61 age-, sex-, and BMI-matched controls. Periostin was measured by ELISA. Associations between periostin levels and clinical variables were assessed using t-tests, Pearson correlations, and multivariable linear regression models.

Results

Mean periostin levels were significantly higher in OI patients than in controls (796.5 ± 209 vs 713.6 ± 167 pmol/L, P = .017). Among OI patients, higher periostin level was associated with female sex (P = .01), presence of scoliosis (P = .01), and Sillence type III (P = .05). Positive correlations were observed between periostin and markers of axial skeletal severity as height–wingspan discrepancy (r = 0.30, P = .023). In multivariable analysis, the number of severe fractures (defined as femur/pelvis/humerus/vertebral fractures) was independently associated with higher periostin level (β = 25.6, P = .041), while smoking was negatively associated (β = −269.8, P = .012).

Conclusion

This study is the first to report the elevated circulating level of periostin in adults with OI and its association with disease severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeriostinOsteogenesis ImperfectaCell Adhesion MoleculesHumansFemaleAdultMaleBiomarkersCase-Control StudiesSeverity of Illness IndexMiddle AgedYoung Adult

Stichwörter der Autor:innen

biomarkerdisease severityosteogenesis imperfectaperiostinrare bone disease

Substanzen

PeriostinPOSTN protein, humanBiomarkersCell Adhesion Molecules

Autor:innen und Institutionen

  • Hospices Civils de Lyon, Hôpital E.Herriot, Service de Rhumatologie et Pathologie Osseuse, Lyon 69003, France.
  • Université de Lyon, Université Lyon 1, INSERM UMR 1033, LYOS Pathophysiology, Diagnosis & Treatments of Musculoskeletal Disorders, Lyon 69008, France.

ORCID-Profile: Alexandre Mercier-Guery, Maxime Auroux, Evelyne Gineyts, Pawel Szulc, Elisabeth Sornay-Rendu, Elisabeth Fontanges, Martine Croset, Jean-Charles Rousseau, Roland Chapurlat

Förderung

  • INSERM
  • 1033 department's own funds
  • University Hospital of Lyon
  • Hospices Civils de Lyon

Zitieren

APA

Mercier-Guery, A., Auroux, M., Gineyts, E., Borel, O., Szulc, P., Sornay-Rendu, E., Fontanges, E., Croset, M., Rousseau, J. C., & Chapurlat, R. (2026). Elevated periostin level in serum of adults with osteogenesis imperfecta is associated with disease severity. The Journal of Clinical Endocrinology & Metabolism, 111(9), 2641-2648. https://doi.org/10.1210/clinem/dgag119

Vancouver

Mercier-Guery A, Auroux M, Gineyts E, Borel O, Szulc P, Sornay-Rendu E, et al. Elevated periostin level in serum of adults with osteogenesis imperfecta is associated with disease severity. The Journal of Clinical Endocrinology & Metabolism. 2026;111(9):2641-2648. doi:10.1210/clinem/dgag119

BibTeX
@article{MercierGuery2026,
  author = {Mercier-Guery, Alexandre and Auroux, Maxime and Gineyts, Evelyne and Borel, Olivier and Szulc, Pawel and Sornay-Rendu, Elisabeth and Fontanges, Elisabeth and Croset, Martine and Rousseau, Jean-Charles and Chapurlat, Roland},
  title = {Elevated periostin level in serum of adults with osteogenesis imperfecta is associated with disease severity},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  volume = {111},
  number = {9},
  pages = {2641--2648},
  doi = {10.1210/clinem/dgag119}
}
Kostenlos starten →